Document And Entity Information
Note To Financial Statement Details Textual
Significant Accounting Policies
us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities
Payments of Contingent consideration
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies
Contingent Consideration [Member]
Liabilities that are contingent on agreed-upon conditions that arise from business combinations.
Other comprehensive income:
London Interbank Offered Rate (LIBOR) [Member]
Note 2 - Selected Balance Sheet Data
us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High
Note 3 - Acquisitions
Note 4 - Fair Value Measurements
Note 6 - Accumulated Other Comprehensive Income
Variable Rate [Domain]
Note 7 - Earnings Per Share
Operating expenses:
Variable Rate [Axis]
Note 9 - Other Income (Expense)
Note 11 - Segment Information
Federal Funds Effective Swap Rate [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Revision of Unaudited Consolidated Financial Statements (Details)
Note 2 - Selected Balance Sheet Data - Inventories (Details)
Note 2 - Selected Balance Sheet Data - Property and Equipment (Details)
Note 2 - Selected Balance Sheet Data - Intangible Assets (Details)
Note 2 - Selected Balance Sheet Data - Changes to Carrying Amount of Net Intangible Assets (Details)
Note 2 - Selected Balance Sheet Data - Estimated Future Amortization Expense for Intangible Assets (Details)
Note 2 - Selected Balance Sheet Data - Changes in Carrying Amount of Goodwill (Details)
Note 2 - Selected Balance Sheet Data - Other Assets (Details)
us-gaap_AvailableForSaleSecurities
Available-for-sale Securities
Note 3 - Acquisitions - Fair Value of Assets and Liabilities Assumed (Details)
us-gaap_PaymentsOfDividendsCommonStock
Cash dividends
tech_PaymentForContingentConsiderationLiability
Payment for Contingent Consideration Liability
The total amount of cash outflow for the acquisition of business combination, to settle contingent consideration liability. Includes the operating and financing activities.
Note 4 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details)
Note 4 - Fair Value Measurements - Liability Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Details)
Note 6 - Accumulated Other Comprehensive Income - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details)
Note 7 - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details)
Unrealized gains and losses on availiable-for-sale investments, net of tax
Adjustments to fair value, cash paid, net of cash acquired
Note 9 - Other Income (Expense) - Schedule of Components of Other Income (Expense) (Details)
Note 11 - Segment Information - Financial Information Relating to Reportable Segments (Details)
Notes To Financial Statements
Notes To Financial Statements [Abstract]
us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
Adjustments to fair value, intangible assets
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 3 [Member]
us-gaap_LineOfCredit
Long-term Line of Credit
Other operating activity
Fair Value Hierarchy [Domain]
Proceeds from stock option exercises
Cash dividends per common share: (in dollars per share)
Fair Value, Hierarchy [Axis]
CASH FLOWS FROM INVESTING ACTIVITIES:
Short-term available-for-sale investments
Equity Component [Domain]
Equity Components [Axis]
Income taxes payable
us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable
Changes in income tax payable
us-gaap_CostMethodInvestments
Investments
us-gaap_ComprehensiveIncomeNetOfTax
Comprehensive income (loss)
Comprehensive income
us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
Business Combination, Liabilities Arising from Contingencies, Amount Recognized
Trade accounts payable and accrued expenses
Salaries, wages and related accruals
us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities
Changes in salaries, wages and related accruals
Supplemental Balance Sheet Disclosures [Text Block]
us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity
Line of Credit Facility, Current Borrowing Capacity
Fair value adjustment to contingent consideration payable
Common stock outstanding (in shares)
us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage
New Accounting Pronouncements, Policy [Policy Text Block]
Investments by Category [Axis]
Asset Class [Axis]
Marketable Securities and Investments Held at Cost [Domain]
Asset Class [Domain]
Diluted (in shares)
us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Long-term debt obligations
us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
Net assets acquired
us-gaap_AvailableForSaleEquitySecuritiesAmortizedCostBasis
Available-for-sale Equity Securities, Amortized Cost Basis
Equity Securities [Member]
us-gaap_LineOfCreditFacilityExpirationDate1
Line of Credit Facility, Expiration Date
Subsequent Event [Member]
Deferred income taxes, net
Diluted (in dollars per share)
Subsequent Event Type [Domain]
Subsequent Event Type [Axis]
Net sales
Cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Subsequent Events [Text Block]
Liabilities
Restatement Adjustment [Member]
Scenario, Previously Reported [Member]
Machinery and Equipment [Member]
Basic (in shares)
Weighted-average shares outstanding – basic (in shares)
Basic (in dollars per share)
Scenario, Unspecified [Domain]
Selling, General and Administrative Expenses [Member]
Equipment and other long-term assets
Scenario, Forecast [Member]
Scenario [Axis]
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
Intangible assets
Debt Disclosure [Text Block]
us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
Current assets, net of cash
Advanced Cell Diagnostics (ACD) [Member]
Represents Advanced Cell Diagnostics (ACD), a leader in the emerging field of molecular pathology, developing cell- and tissue-based research and diagnostic tests for personalized medicine.
us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities
Segment Reconciling Items [Member]
Income Statement Location [Domain]
Cash paid, net of cash acquired
Business Combination, Consideration Transferred
Consolidation Items [Domain]
Income Statement Location [Axis]
Consolidation Items [Axis]
Intersegment Eliminations [Member]
Borrowings under line-of-credit agreement
Operating Segments [Member]
Maximum [Member]
Range [Domain]
Minimum [Member]
Range [Axis]
Accounting Policies [Abstract]
Statement of Financial Position [Abstract]
us-gaap_IncreaseDecreaseInPrepaidExpense
Prepaid expenses
us-gaap_BusinessCombinationContingentConsiderationLiability
Contingent Consideration
Investment, Name [Domain]
Trevigen Inc. [Member]
Information pertaining to Trevigen Inc.
Statement of Cash Flows [Abstract]
Fair Value by Liability Class [Domain]
Liability Class [Axis]
Investment, Name [Axis]
Costs recognized on sale of acquired inventory
The noncash expense during the period from the sale of acquired inventory written up to fair value in purchase accounting.
us-gaap_RepaymentsOfLinesOfCredit
Payments on line-of-credit
us-gaap_AllocatedShareBasedCompensationExpense
Allocated Share-based Compensation Expense
Stock based compensation
us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses
Available-for-sale Securities, Gross Realized Losses
us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Change in fair value of contingent consideration
Schedule of Intangible Assets and Goodwill [Table Text Block]
us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables
Trade accounts and other receivables
Geographical [Domain]
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Investment [Axis]
Tax Credit Carryforward [Axis]
Geographical [Axis]
Long-term contingent consideration payable
Tax Credit Carryforward, Name [Domain]
Other long-term liabilities
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Trade Names [Member]
Deferred income taxes
us-gaap_LiabilitiesAndStockholdersEquity
Total liabilities and shareholders’ equity
Investment [Domain]
us-gaap_EffectiveIncomeTaxRateContinuingOperations
Effective Income Tax Rate Reconciliation, Percent
Income tax expense (benefit)
Retained earnings
Accumulated other comprehensive loss
Segments [Axis]
Segments [Domain]
us-gaap_PolicyTextBlockAbstract
Accounting Policies
us-gaap_IncreaseDecreaseInInventories
Inventories
Corporate Debt Securities [Member]
us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
Fair value at the beginning of period
Fair value at the end of period
Credit Facility [Domain]
Statement [Table]
Revolving Credit Facility [Member]
Available-for-sale Securities [Member]
Credit Facility [Axis]
Noncompete Agreements [Member]
us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
Payments
Income Statement [Abstract]
CASH FLOWS FROM FINANCING ACTIVITIES:
us-gaap_AccruedIncomeTaxesNoncurrent
Accrued Income Taxes, Noncurrent
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Developed Technology Rights [Member]
Patents [Member]
Class of Stock [Axis]
Award Type [Axis]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Equity Award [Domain]
Biotechnology [Member]
Information about the company's Biotechnology segment.
Customer Relationships [Member]
Protein Platforms [Member]
Information about the company's Protein Platforms segment.
us-gaap_OtherAssetsMiscellaneousNoncurrent
Other
tech_LineOfCreditFacilityAdditionalBorrowingCapacity
Line of Credit Facility, Additional Borrowing Capacity
The element representing the additional borrowing capacity under a line of credit.
CyVek, Inc. [Member]
Information concerning, or mentioned in connection with, the entity CyVek, Inc.
Finite-Lived Intangible Assets, Major Class Name [Domain]
Segment Reporting Disclosure [Text Block]
Schedule of Other Assets, Noncurrent [Table Text Block]
Finite-Lived Intangible Assets by Major Class [Axis]
us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
CHINA
Prepaid expenses and other
Atlanta Biologicals [Member]
Represents information pertaining Atlanta Biologicals.
us-gaap_PaymentsToAcquireInterestInJointVenture
Purchase of equity investment
us-gaap_DisclosureTextBlockAbstract
Notes to Financial Statements
us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Payments to Acquire Businesses, Net of Cash Acquired
Acquisitions, net of cash acquired
us-gaap_LiabilitiesCurrent
Total current liabilities
tech_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRevaluationOfContingentConsideration
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Revaluation of Contingent Consideration
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expense related to the revaluation of contingent consideration.
Raw materials
us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent
Contingent consideration payable
Finished goods
Other income (expense)
Other (expense) income
Total other income (expense)
Other non-operating income (expense), net
us-gaap_OperatingExpenses
Total operating expenses
Zephyrus [Member]
Information about Zephyrus.
Change in operating assets and operating liabilities, net of acquisition:
Adjustments to fair value, goodwill
Goodwill, Purchase Accounting Adjustments
tech_IncomeTaxExpenseBenefitDiscreteTaxItems
Income Tax Expense (Benefit), Discrete Tax Items
Represents the income tax expense (benefit) related to discrete tax items.
Property, Plant and Equipment [Table Text Block]
us-gaap_GoodwillForeignCurrencyTranslationGainLoss
Currency translation
us-gaap_InvestmentIncomeNet
Interest income
Certificates Of Deposit [Member]
Information pertaining to certificates of deposits.
ChemoCentryx, Inc (CCXI) [Member]
Represents ChemoCentryx, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer primarily focused on orphan and rare diseases.
us-gaap_GoodwillAcquiredDuringPeriod
Acquisitions (Note 3)
Operating income
Operating income
Deferred revenue
Schedule of Inventory, Current [Table Text Block]
Business Combination Disclosure [Text Block]
Deferred income taxes
us-gaap_DeferredIncomeTaxExpenseBenefit
us-gaap_GrossProfit
Gross margin
Amendment Flag
Thereafter
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 37,469,896 and 37,356,041, respectively
Cost of sales
2020
2019
2022
2021
2018
us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
Excess tax benefit from stock option exercises
Common stock authorized (in shares)
Common stock issued (in shares)
Other assets
Other Assets, Noncurrent
Other assets
Common stock par value (in dollars per share)
Income Tax Disclosure [Text Block]
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Stock-based compensation expense
us-gaap_ShareBasedCompensation
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Fair Value, Measurement Inputs, Disclosure [Text Block]
Proceeds from maturities of available-for-sale investments
Current Fiscal Year End Date
Document Fiscal Period Focus
Astute Medical, Inc. [Member]
The acquired investment of Astute Medical, Inc.
Document Fiscal Year Focus
tech_FinitelivedIntangibleAssetsOtherAdditions
Other additions
Amount of other additions lacking physical substance with a definite life.
Document Period End Date
us-gaap_FiniteLivedIntangibleAssetUsefulLife
Finite-Lived Intangible Asset, Useful Life
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Document Type
us-gaap_BusinessCombinationAcquisitionRelatedCosts
Acquisition related expenses
Income taxes payable
Accrued Income Taxes, Current
us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
Other comprehensive income (loss)
Other comprehensive (loss) income
us-gaap_PaymentsToAcquireInvestments
Payments to Acquire Investments
us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
Currency translation
Depreciation and amortization
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Trade accounts payable
Document Information [Line Items]
Document Information [Table]
Salaries, wages and related accruals
us-gaap_AssetsCurrent
Total current assets
Accrued expenses
us-gaap_GoodwillImpairmentLoss
Goodwill, Impairment Loss
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
Entity Filer Category
us-gaap_FinitelivedIntangibleAssetsAcquired1
Acquisitions
Entity Current Reporting Status
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Entity Voluntary Filers
Entity Well-known Seasoned Issuer
us-gaap_PaymentsToAcquireAvailableForSaleSecurities
Payments to Acquire Available-for-sale Securities
Purchases of available-for-sale investments
us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability
us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
tech_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentAssetsNetOfCash
Adjustments to fair value, current assets, net of cash
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to current assets (net of cash) acquired in connection with a business combination for which the initial accounting was incomplete.
us-gaap_AmortizationOfIntangibleAssets
Amortization of acquisition related intangible assets
Amortization expense
Adjustments to fair value, total assets acquired
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to all assets acquired (including goodwill) in connection with a business combination for which the initial accounting was incomplete.
Adjustments to fair value, liabilities
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to liabilities assumed in connection with a business combination for which the initial accounting was incomplete.
Adjustments to reconcile net earnings to net cash provided by operating activities:
Adjustments to fair value, equipment and other long-term assets
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to equipment and other long-term assets acquired in connection with a business combination for which the initial accounting was incomplete.
Dilutive effect of stock options and restricted stock units (in shares)
Acquisition Related [Member]
The expenses related to acquisitions.
Entity Central Index Key
Eurocell Diagnostics, SAS [Member]
Represents information pertaining Eurocell Diagnostics, SAS
Entity Registrant Name
tech_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentsNewLegislation
Income Tax Expense (Benefit), Continuing Operations, Adjustments, New Legislation
Represents the total amount of adjustments on income taxes related to newly enacted legislation.
Adjustments to fair value, deferred income taxes, net
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to deferred income tax liabilities assumed in connection with a business combination for which the initial accounting was incomplete.
tech_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets
Adjustments to fair value, net assets acquired
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to assets (net liabilities) acquired in connection with a business combination for which the initial accounting was incomplete.
Total Assets
Entity [Domain]
Transition Tax [Member]
Information regarding the transition tax.
Legal Entity [Axis]
Weighted average common shares outstanding:
tech_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentsOnTransitionTax
Income Tax Expense (Benefit), Continuing Operations, Adjustments on Transition Tax
The amount of adjustments recognized on income tax expense (benefit) for adjustments on transition tax.
Total assets acquired
Amount of assets acquired, including goodwill, at the acquisition date.
Current liabilities:
Schedule of Goodwill [Table Text Block]
us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
Income available to common shareholders
Schedule of Other Nonoperating Income (Expense) [Table Text Block]
Entity Common Stock, Shares Outstanding (in shares)
Cash paid for income taxes
Corporate securities
us-gaap_InvestmentsFairValueDisclosure
us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted
Income available to common shareholders
LIABILITIES AND SHAREHOLDERS' EQUITY
us-gaap_Assets
Total assets
Additional paid-in capital
Cash paid for interest
Inventories
Inventories, net
us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
Income allocated to participating securities
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Trading Symbol
Comprehensive Income (Loss) Note [Text Block]
Other Income and Other Expense Disclosure [Text Block]
us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Purchases of property and equipment
Net earnings
Net earnings
Net income
Business Description and Accounting Policies [Text Block]
us-gaap_StockholdersEquity
Total shareholders' equity
Beginning balance
Ending balance
Selling, general and administrative
Corporate general, selling, and administrative expenses
us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized
us-gaap_NumberOfReportingUnits
Number of Reporting Units
us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition
Restricted Stock Units (RSUs) [Member]
us-gaap_CostOfGoodsSold
Costs recognized on sale of acquired inventory
Restricted Stock [Member]
Intangible assets, net
Intangible assets, net
Beginning balance
Ending balance
us-gaap_FiniteLivedIntangibleAssetsNet
Total
Diagnostics [Member]
Represents the company's Diagnostics segment, a segment was focused on controls and calibrators for hematology clinical instruments.
CASH FLOWS FROM OPERATING ACTIVITIES:
us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
Accumulated amortization
us-gaap_FiniteLivedIntangibleAssetsGross
Intangible assets
Accounts receivable, allowance for doubtful accounts
Accounts receivable, less allowance for doubtful accounts of $905 and $696, respectively
Statement [Line Items]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Research and development
Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
us-gaap_InterestExpense
Interest expense
Supplemental disclosure of cash flow information:
AOCI Attributable to Parent [Member]
Unrealized gain (loss) on available-for-sale investments, net of tax of $799, $(1,889), $5,375, and $(2,060), respectively
Goodwill
Beginning balance
Ending balance
Current assets:
Property and equipment, net
Property and equipment, net
ASSETS
us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
Accumulated depreciation and amortization
Property and equipment, cost
Foreign currency translation adjustments
Advance Cell Diagnostics (ACD), Zephyrus, and CyVek Inc.[Member]
Represents the acquisitions of Advance Cell Diagnostics (ACD), Zephyrus, and CyVek, Inc.
us-gaap_NetCashProvidedByUsedInFinancingActivities
Net cash (used in) provided by financing activities
us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
Debt Instrument, Basis Spread on Variable Rate
Building and Building Improvements [Member]
us-gaap_NetCashProvidedByUsedInInvestingActivities
Net cash used in investing activities
us-gaap_NetCashProvidedByUsedInOperatingActivities
Net cash provided by operating activities
us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Net increase (decrease) in cash and cash equivalents
us-gaap_TableTextBlock
Notes Tables
Effect of exchange rate changes on cash and cash equivalents
Property, Plant and Equipment, Type [Domain]
Property, Plant and Equipment, Type [Axis]
Land [Member]
Earnings before income taxes
Shareholders' equity:
Other financing
Business Acquisition, Acquiree [Domain]
Earnings Per Share [Text Block]
Business Acquisition [Axis]
Earnings per share: